Studies on Antidiabetic Agents. II. Synthesis of 5-[4-(1-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and Its Derivatives

212Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

More than 100 5-substituted thiazolidine-2,4-diones were prepared and their hypoglycemic and hypolipidemic activities were evaluated with genetically obese and diabetic mice, yellow KK. The structure-activity relationship study showed that the 5-(4-oxybenzyl) moiety is essential for substantial activity. Among these compounds, 5-(4-cyclohexyl-methoxy)benzylthiazolidine-2,4-dione (47), 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (49, ADD-3878) and 5-{4-[2-(3-pyridyl)ethoxy]benzyl}thiazolidine-2,4-dione (59) exhibited the most favorable properties in terms of activity and toxicity. © 1982, The Pharmaceutical Society of Japan. All rights reserved.

Cite

CITATION STYLE

APA

Sohda, T., Mizuno, K., Imamiya, E., Sugiyama, Y., Fujita, T., & Kawamatsu, Y. (1982). Studies on Antidiabetic Agents. II. Synthesis of 5-[4-(1-Methylcyclohexylmethoxy)-benzyl]thiazolidine-2,4-dione (ADD-3878) and Its Derivatives. Chemical and Pharmaceutical Bulletin, 30(10), 3580–3600. https://doi.org/10.1248/cpb.30.3580

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free